Global OPO Infant Formula Market Research Report 2023

Publication ID:

PB502241087

Publication Date:

February 9, 2023

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

Food Processing [2]

Food [3]

Food & Beverages [4]

Description:

OPO is a structured triglyceride where palmitic acid bonded to the middle position (sn-2) of the glycerol backbone. Structured triglycerides are achieved through an enzymatic process using vegetable oils. The development of sn-2 Palmitate structured triglycerides enables mimicking both the composition as well as the structure of human milk fat. Vegetable oils that are commonly used as source for infant formula fat have the opposite structure where the palmitic is located mainly at sn-1 and sn-3 positions. Enzymatic process on vegetable oils enables changing the position of palmitic acid to the sn-2 position. Clinical studies in preterm and term infants, as well as preclinical animal model studies, show that enrichment of infant formula with sn-2 Palmitate results in increased fat absorption, reduced calcium soaps formation and stool hardness, increased calcium retention and larger skeletal mineral deposition.
Highlights
The global OPO Infant Formula market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Netherlands-Ukraine War were considered while estimating market sizes.
North American market for OPO Infant Formula is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for OPO Infant Formula is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global manufacturers of OPO Infant Formula include BiosTime, Nutriben, Ausnutria, HERDS, Milupa, Shanxi Yatai, Beingmate, Abbott and Brightdairy, etc. in 2022, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for OPO Infant Formula, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding OPO Infant Formula.
The OPO Infant Formula market size, estimations, and forecasts are provided in terms of sales volume (K MT) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global OPO Infant Formula market comprehensively. Regional market sizes, concerning products by type, by application and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the OPO Infant Formula manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by type, by application and by regions.
By Company
BiosTime
Nutriben
Ausnutria
HERDS
Milupa
Shanxi Yatai
Beingmate
Abbott
Brightdairy
Feihe
Wyeth Nutrition
Deloraine
Yili
Kabrita
Segment by Type
Cow Milk Formula
Goat Milk Formula
Segment by Application
0 - 6 Month
6 - 12 Month
12 - 36 Month
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of OPO Infant Formula manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of OPO Infant Formula in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 OPO Infant Formula Market Overview
1.1 Product Overview and Scope of OPO Infant Formula
1.2 OPO Infant Formula Segment by Type
1.2.1 Global OPO Infant Formula Market Value Comparison by Type (2023-2029)
1.2.2 Cow Milk Formula
1.2.3 Goat Milk Formula
1.3 OPO Infant Formula Segment by Application
1.3.1 Global OPO Infant Formula Market Value by Application: (2023-2029)
1.3.2 0 - 6 Month
1.3.3 6 - 12 Month
1.3.4 12 - 36 Month
1.4 Global OPO Infant Formula Market Size Estimates and Forecasts
1.4.1 Global OPO Infant Formula Revenue 2018-2029
1.4.2 Global OPO Infant Formula Sales 2018-2029
1.4.3 Global OPO Infant Formula Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 OPO Infant Formula Market Competition by Manufacturers
2.1 Global OPO Infant Formula Sales Market Share by Manufacturers (2018-2023)
2.2 Global OPO Infant Formula Revenue Market Share by Manufacturers (2018-2023)
2.3 Global OPO Infant Formula Average Price by Manufacturers (2018-2023)
2.4 Global OPO Infant Formula Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of OPO Infant Formula, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of OPO Infant Formula, Product Type & Application
2.7 OPO Infant Formula Market Competitive Situation and Trends
2.7.1 OPO Infant Formula Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest OPO Infant Formula Players Market Share by Revenue
2.7.3 Global OPO Infant Formula Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 OPO Infant Formula Retrospective Market Scenario by Region
3.1 Global OPO Infant Formula Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global OPO Infant Formula Global OPO Infant Formula Sales by Region: 2018-2029
3.2.1 Global OPO Infant Formula Sales by Region: 2018-2023
3.2.2 Global OPO Infant Formula Sales by Region: 2024-2029
3.3 Global OPO Infant Formula Global OPO Infant Formula Revenue by Region: 2018-2029
3.3.1 Global OPO Infant Formula Revenue by Region: 2018-2023
3.3.2 Global OPO Infant Formula Revenue by Region: 2024-2029
3.4 North America OPO Infant Formula Market Facts & Figures by Country
3.4.1 North America OPO Infant Formula Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America OPO Infant Formula Sales by Country (2018-2029)
3.4.3 North America OPO Infant Formula Revenue by Country (2018-2029)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe OPO Infant Formula Market Facts & Figures by Country
3.5.1 Europe OPO Infant Formula Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe OPO Infant Formula Sales by Country (2018-2029)
3.5.3 Europe OPO Infant Formula Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific OPO Infant Formula Market Facts & Figures by Country
3.6.1 Asia Pacific OPO Infant Formula Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific OPO Infant Formula Sales by Country (2018-2029)
3.6.3 Asia Pacific OPO Infant Formula Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America OPO Infant Formula Market Facts & Figures by Country
3.7.1 Latin America OPO Infant Formula Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America OPO Infant Formula Sales by Country (2018-2029)
3.7.3 Latin America OPO Infant Formula Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa OPO Infant Formula Market Facts & Figures by Country
3.8.1 Middle East and Africa OPO Infant Formula Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa OPO Infant Formula Sales by Country (2018-2029)
3.8.3 Middle East and Africa OPO Infant Formula Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global OPO Infant Formula Sales by Type (2018-2029)
4.1.1 Global OPO Infant Formula Sales by Type (2018-2023)
4.1.2 Global OPO Infant Formula Sales by Type (2024-2029)
4.1.3 Global OPO Infant Formula Sales Market Share by Type (2018-2029)
4.2 Global OPO Infant Formula Revenue by Type (2018-2029)
4.2.1 Global OPO Infant Formula Revenue by Type (2018-2023)
4.2.2 Global OPO Infant Formula Revenue by Type (2024-2029)
4.2.3 Global OPO Infant Formula Revenue Market Share by Type (2018-2029)
4.3 Global OPO Infant Formula Price by Type (2018-2029)
5 Segment by Application
5.1 Global OPO Infant Formula Sales by Application (2018-2029)
5.1.1 Global OPO Infant Formula Sales by Application (2018-2023)
5.1.2 Global OPO Infant Formula Sales by Application (2024-2029)
5.1.3 Global OPO Infant Formula Sales Market Share by Application (2018-2029)
5.2 Global OPO Infant Formula Revenue by Application (2018-2029)
5.2.1 Global OPO Infant Formula Revenue by Application (2018-2023)
5.2.2 Global OPO Infant Formula Revenue by Application (2024-2029)
5.2.3 Global OPO Infant Formula Revenue Market Share by Application (2018-2029)
5.3 Global OPO Infant Formula Price by Application (2018-2029)
6 Key Companies Profiled
6.1 BiosTime
6.1.1 BiosTime Corporation Information
6.1.2 BiosTime Description and Business Overview
6.1.3 BiosTime OPO Infant Formula Sales, Revenue and Gross Margin (2018-2023)
6.1.4 BiosTime OPO Infant Formula Product Portfolio
6.1.5 BiosTime Recent Developments/Updates
6.2 Nutriben
6.2.1 Nutriben Corporation Information
6.2.2 Nutriben Description and Business Overview
6.2.3 Nutriben OPO Infant Formula Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Nutriben OPO Infant Formula Product Portfolio
6.2.5 Nutriben Recent Developments/Updates
6.3 Ausnutria
6.3.1 Ausnutria Corporation Information
6.3.2 Ausnutria Description and Business Overview
6.3.3 Ausnutria OPO Infant Formula Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Ausnutria OPO Infant Formula Product Portfolio
6.3.5 Ausnutria Recent Developments/Updates
6.4 HERDS
6.4.1 HERDS Corporation Information
6.4.2 HERDS Description and Business Overview
6.4.3 HERDS OPO Infant Formula Sales, Revenue and Gross Margin (2018-2023)
6.4.4 HERDS OPO Infant Formula Product Portfolio
6.4.5 HERDS Recent Developments/Updates
6.5 Milupa
6.5.1 Milupa Corporation Information
6.5.2 Milupa Description and Business Overview
6.5.3 Milupa OPO Infant Formula Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Milupa OPO Infant Formula Product Portfolio
6.5.5 Milupa Recent Developments/Updates
6.6 Shanxi Yatai
6.6.1 Shanxi Yatai Corporation Information
6.6.2 Shanxi Yatai Description and Business Overview
6.6.3 Shanxi Yatai OPO Infant Formula Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Shanxi Yatai OPO Infant Formula Product Portfolio
6.6.5 Shanxi Yatai Recent Developments/Updates
6.7 Beingmate
6.6.1 Beingmate Corporation Information
6.6.2 Beingmate Description and Business Overview
6.6.3 Beingmate OPO Infant Formula Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Beingmate OPO Infant Formula Product Portfolio
6.7.5 Beingmate Recent Developments/Updates
6.8 Abbott
6.8.1 Abbott Corporation Information
6.8.2 Abbott Description and Business Overview
6.8.3 Abbott OPO Infant Formula Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Abbott OPO Infant Formula Product Portfolio
6.8.5 Abbott Recent Developments/Updates
6.9 Brightdairy
6.9.1 Brightdairy Corporation Information
6.9.2 Brightdairy Description and Business Overview
6.9.3 Brightdairy OPO Infant Formula Sales, Revenue and Gross Margin (2018-2023)
6.9.4 Brightdairy OPO Infant Formula Product Portfolio
6.9.5 Brightdairy Recent Developments/Updates
6.10 Feihe
6.10.1 Feihe Corporation Information
6.10.2 Feihe Description and Business Overview
6.10.3 Feihe OPO Infant Formula Sales, Revenue and Gross Margin (2018-2023)
6.10.4 Feihe OPO Infant Formula Product Portfolio
6.10.5 Feihe Recent Developments/Updates
6.11 Wyeth Nutrition
6.11.1 Wyeth Nutrition Corporation Information
6.11.2 Wyeth Nutrition OPO Infant Formula Description and Business Overview
6.11.3 Wyeth Nutrition OPO Infant Formula Sales, Revenue and Gross Margin (2018-2023)
6.11.4 Wyeth Nutrition OPO Infant Formula Product Portfolio
6.11.5 Wyeth Nutrition Recent Developments/Updates
6.12 Deloraine
6.12.1 Deloraine Corporation Information
6.12.2 Deloraine OPO Infant Formula Description and Business Overview
6.12.3 Deloraine OPO Infant Formula Sales, Revenue and Gross Margin (2018-2023)
6.12.4 Deloraine OPO Infant Formula Product Portfolio
6.12.5 Deloraine Recent Developments/Updates
6.13 Yili
6.13.1 Yili Corporation Information
6.13.2 Yili OPO Infant Formula Description and Business Overview
6.13.3 Yili OPO Infant Formula Sales, Revenue and Gross Margin (2018-2023)
6.13.4 Yili OPO Infant Formula Product Portfolio
6.13.5 Yili Recent Developments/Updates
6.14 Kabrita
6.14.1 Kabrita Corporation Information
6.14.2 Kabrita OPO Infant Formula Description and Business Overview
6.14.3 Kabrita OPO Infant Formula Sales, Revenue and Gross Margin (2018-2023)
6.14.4 Kabrita OPO Infant Formula Product Portfolio
6.14.5 Kabrita Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 OPO Infant Formula Industry Chain Analysis
7.2 OPO Infant Formula Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 OPO Infant Formula Production Mode & Process
7.4 OPO Infant Formula Sales and Marketing
7.4.1 OPO Infant Formula Sales Channels
7.4.2 OPO Infant Formula Distributors
7.5 OPO Infant Formula Customers
8 OPO Infant Formula Market Dynamics
8.1 OPO Infant Formula Industry Trends
8.2 OPO Infant Formula Market Drivers
8.3 OPO Infant Formula Market Challenges
8.4 OPO Infant Formula Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

Companies Mentioned:

BiosTime
Nutriben
Ausnutria
HERDS
Milupa
Shanxi Yatai
Beingmate
Abbott
Brightdairy
Feihe
Wyeth Nutrition
Deloraine
Yili
Kabrita

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂